rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-5-10
|
pubmed:abstractText |
C34T variant of adenosine monophosphate deaminase 1 (AMPD1) gene has been associated with a prolonged survival in heart failure and coronary artery disease, hypothetically linked to an enhanced production of adenosine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0167-5273
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-5
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15882662-AMP Deaminase,
pubmed-meshheading:15882662-Adenosine,
pubmed-meshheading:15882662-Aged,
pubmed-meshheading:15882662-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15882662-Coronary Artery Bypass,
pubmed-meshheading:15882662-Coronary Artery Disease,
pubmed-meshheading:15882662-Female,
pubmed-meshheading:15882662-Follow-Up Studies,
pubmed-meshheading:15882662-Genotype,
pubmed-meshheading:15882662-Humans,
pubmed-meshheading:15882662-Male,
pubmed-meshheading:15882662-Middle Aged,
pubmed-meshheading:15882662-Polymorphism, Genetic,
pubmed-meshheading:15882662-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
|
pubmed:affiliation |
Institute of Clinical Physiology, Pisa, Italy. andreas@ifc.cnr.it
|
pubmed:publicationType |
Journal Article
|